| 1. | Application of neoadjuvant chemotherapy in treatment of cervical cancer
新辅助化疗在宫颈癌中的应用 |
| 2. | Neoadjuvant treatment for esophageal
食管癌的新辅助治疗 |
| 3. | Objective : to evaluate the status quo of the application of neoadjuvant chemotherapy
目的:对新辅助化疗方案的临床应用现状进行评价。 |
| 4. | Neoadjuvant chemotherapy with pirarubicin taxol regiment for the treatment of locally advanced breast cancer
方案三种化疗方法治疗非小细胞肺癌的疗效观察 |
| 5. | To investigate , the researchers studied stage ii and ii breast cancer patients who were receiving neoadjuvant chemotherapy
研究人员对接受新辅助化疗的ii期乳腺癌患者进行了研究。 |
| 6. | The most notable notion is to administer neoadjuvant chemotherapy to reduce the size of the primary tumor before surgery
其中最令人关注的主张是在手术前以新辅助化疗缩小原发性肿瘤的大小。 |
| 7. | The expression of bcl - 2 and survivin protein and its relationship with therapeutic response of neoadjuvant chemotherapy in patients with breast cancer
2和生存素的表达及其与化疗反应的相关性 |
| 8. | For patients with pathologic complete response , neoadjuvant therapy may give additional benefit in prolonging overall survival
对于病理完全缓解的患者，新辅助治疗可以带来延长总体生存时间的益处。 |
| 9. | However , concern has arisen regarding the potential for vascular complications due to high - dose neoadjuvant therapy before transplantation
但是，人们担心移植前的高剂量新辅助治疗有可能引发血管并发症。 |
| 10. | Conclusion : : the multimodality treatment of stage iii and iva thymomas by means of neoadjuvant chemotherapy provides good long - term outcomes in both stages of the disease
：用新辅助化疗的方法治疗iii期和iva期胸腺瘤，为这两期患者的治疗提供了良好的长期的预后。 |
